Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CBR Agonist-2

CBR Agonist-2 is a CB1 agonist (CB1R; CB1 ligand) with an EC50 and a Ki of 960 nM and 970 nM, respectively. CBR Agonist-2 is a promising tool for investigating the involvement of hCB1R in disorders associated with the endocannabinoid system[1].

Product Specifications

UNSPSC

12352005

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

Neuroscience-Neuromodulation

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/cbr-agonist-2.html

Solubility

10 mM in DMSO

Smiles

O=C(C1=CN(C2=CC=CC=C12)CCCCCF)NCC3=CC=CC=C3/N=N/C4=CC=CC=C4

Molecular Formula

C27H27FN4O

Molecular Weight

442.53

References & Citations

[1]Diego A Rodríguez-Soacha, et al. Development of an Indole-Amide-Based Photoswitchable Cannabinoid Receptor Subtype 1 (CB 1 R) "Cis-On" Agonist. ACS Chem Neurosci.2022 Jul 26. doi: 10.1021/acschemneuro.2c00160.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CB1

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Lentiviral human C5orf52 shRNA (UAS) - Lentiviral human C5orf52 shRNA (UAS, iRFP) (25)
GTR15324101 1 Vial

Lentiviral human C5orf52 shRNA (UAS) - Lentiviral human C5orf52 shRNA (UAS, iRFP) (25)

Ask
View Details
Ɑ-Methoxy-ω-Succinamic Acid PEG
122000-3.1G 1 g

Ɑ-Methoxy-ω-Succinamic Acid PEG

Ask
View Details
RPL21P69 AAV Vector (Human) (CMV)
41074101 1 µg

RPL21P69 AAV Vector (Human) (CMV)

Ask
View Details
Tissue, Total Protein, Human Tumor, lymphoma, Non-Hodgkin’s HisTekTM
T5595-6869 1 mg

Tissue, Total Protein, Human Tumor, lymphoma, Non-Hodgkin’s HisTekTM

Ask
View Details
β-Amyloid, NT (MaxLight 750) discontinued
A2275-73D-ML750 100 µL

β-Amyloid, NT (MaxLight 750) discontinued

Ask
View Details